Drug intelligence / Profile preview

colaspase + mercaptopurine + prednisolone + vincristine

Development stage
Unknown
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

A combination chemotherapy regimen used primarily for the treatment of acute lymphoblastic leukemia (ALL). This regimen combines four agents with different mechanisms of action: colaspase (L-asparaginase/PEG-asparaginase) which depletes asparagine essential for leukemic cell survival, mercaptopurine which interferes with nucleic acid biosynthesis, prednisolone which has anti-inflammatory and immunosuppressive properties, and vincristine which disrupts microtubule formation preventing cell division. This combination is used in various phases of ALL treatment including induction, consolidation, and maintenance therapy.

Other names
L-asparaginase + mercaptopurine + prednisolone + vincristinePEG-asparaginase + mercaptopurine + prednisolone + vincristine
02

Targets

GR (Glucocorticoid receptor)TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on colaspase + mercaptopurine + prednisolone + vincristine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colaspase + mercaptopurine + prednisolone + vincristine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call